Companies/JP/4554

FUJI PHARMA CO., LTD. · 富士製薬工業株式会社

Income flow

Annual
4554 ANNUAL Income StatementPeriod 2025-09-30Source ANNUAL
Net salesJPY 52B+12% Y/YRevenueJPY 52B+12% Y/YGross profitJPY 21B+16% Y/YCost of revenueJPY 31BOperating profitJPY 5B+29% Y/YOperating expensesJPY 16BNet profitJPY 3B-51% Y/YTaxJPY 1BSG&AJPY 16B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).2.67%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.2.75%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).45.5PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.37.9%Shares outTotal shares currently outstanding (issued and not retired).26.1MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).14.4M
Dividend calendar
Ex-dividend
2026-09-29
Last cash
26 · 2026-09-29
Stock splits
  1. 2:12018-06-27